## EG: Everest Group, Ltd. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 2.1% below STRENGTH zone (3.0-6.0%); PEG unavailable fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.2% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($322.53)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Neutral (Bullish: 2, Bearish: 0)

**1. Trueman and Shaw take senior roles at Everest wholesale and specialty**
- Source: Global Reinsurance | 20251222T140828 | Bullish | Relevance: 100%
- Everest Group has appointed Paul Trueman as head of international and Mark Shaw as global head of commercial within its global wholesale and specialty insurance division. These appointments are effective immediately and are part of Everest's strategy to strengthen its wholesale and specialty platform, focusing on disciplined underwriting and closer broker alignment. Both Trueman and Shaw joined Everest in 2022 and have significant experience in the specialty insurance market.

**2. Global: Everest announces leadership appointments**
- Source: Asia Insurance Review | 20251222T000358 | Bullish | Relevance: 100%
- Everest Group has appointed Mr. Mark Shaw as Global Head of Commercial, Global Wholesale and Specialty and Mr. Paul Trueman as Head of International, Global Wholesale and Specialty. Mr. Shaw will lead the firmâ€™s global commercial insurance strategy, while Mr. Trueman will oversee underwriting, distribution, and portfolio strategy across international markets. Both joined Everest in 2022 and have been instrumental in enhancing the company's market reach and specialty capabilities.

**3. Osaic Holdings Inc. Purchases 23,924 Shares of Everest Group, Ltd. $EG**
- Source: MarketBeat | 20251221T110755 | Neutral | Relevance: 100%
- Osaic Holdings Inc. significantly increased its stake in Everest Group, Ltd. (NYSE:EG) by purchasing an additional 23,924 shares, bringing its total holdings to 25,208 shares valued at $9.14 million. This move represents an 1,863.2% increase in their position. The article also details other institutional investor activities, Everest Group's financial performance including a quarterly dividend, and recent analyst ratings.

**4. Is A High-Conviction Analyst Downgrade Altering The Investment Case For Everest Group (EG)?**
- Source: Simply Wall Street | 20251221T023947 | Somewhat-Bearish | Relevance: 100%
- Mizuho Securities analyst Yaron Kinar downgraded Everest Group (EG) to a hold rating with a price target cut from US$415 to US$359, reflecting a more cautious view due to Everest's growing property catastrophe exposure. Despite this, Everest's continued US$2.00 quarterly dividend signals board confidence in capital strength. Investors should consider diverse fair value estimates and potential impacts on future earnings stability.

**5. Is A High-Conviction Analyst Downgrade Altering The Investment Case For Everest Group (EG)?**
- Source: Simply Wall Street | 20251221T020808 | Neutral | Relevance: 100%
- Mizuho Securities analyst Yaron Kinar recently downgraded Everest Group (EG) to a hold rating, citing a more cautious stance on the insurer. This high-conviction downgrade, coming from an analyst with a strong track record, prompts an assessment of how it might impact Everest Group's investment narrative and risk-reward profile, particularly given its exposure to property catastrophe risk. Investors are encouraged to consider various perspectives and the impact on earnings stability before drawing conclusions.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Mizuho | $359 | $0 | 0% |
| 2025-12-15 | TD Cowen | $365 | $400 | -9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Mizuho | init | Neutral |
| 2025-12-15 | TD Cowen | main | Hold |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 6 |

**Top Holders:**
- Vanguard Group Inc: 13.1% (-1.0%)
- Blackrock Inc.: 8.1% (-2.9%)
- AQR Capital Manageme: 4.8% (+70.3%)
- State Street Corpora: 4.5% (-0.7%)
- Vulcan Value Partner: 3.4% (+13.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

Forward P/E 6.1x attractive for 24% earnings growth. Balance sheet: strong liquidity (11.3x). Revenue declining -7% YoY, concerning. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (3 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $14.1B |
| Beta | 0.38 |
| 52W Range | $302.44 - $373.23 |
| Short Interest | 2.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | -50.00 |
| Forward P/E | 6.1 |
| Current P/E | 7.5 |
| YoY Growth | 24.0% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 4.3% to 2.1% (-2.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 0.9pp (needs >3.0% for momentum thesis). MRS_5 (-0.0%) diverging from MRS_10 - short-term weakness emerging. Below SMA200 (0.99x), long-term trend not supportive. MACD histogram positive (2.81), confirming momentum. OFD pattern: +MTL (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.15% (CS: 83) | Neutral |
| RSI_14 | 65.2 | Neutral |
| MACD Histogram | 2.81 | Bullish |
| vs SMA20 | 1.052x | Above |
| vs SMA50 | 1.032x | Above |
| vs SMA200 | 0.990x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $335.65
- **Stop Loss:** $322.53 (3.9% risk)
- **Target:** $348.77 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 68
- **Position Value:** $22,824.20
- **Portfolio %:** 22.82%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-02-02 (Est: $13.08)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $14.52 | $7.54 | -48.1% |
| 2025Q2 | $14.82 | $17.36 | +17.1% |
| 2025Q1 | $7.74 | $6.45 | -16.7% |
| 2024Q4 | $-17.42 | $-18.39 | -5.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*